Stem Cell :: Stem cells provide clues to cancer spread
Scientists have made a breakthrough in understanding how cancers spread in what could lead to new ways of beating the disease.
Scientists have made a breakthrough in understanding how cancers spread in what could lead to new ways of beating the disease.
Researchers in Tuebingen, Germany, investigated the possibility of isolating stem cells from human testicular parenchyma and whether those cells could them be differentiated into the different tissues of the three human germ layers: mesoderm, endoderm and ectoderm.
Human fatty tissue has been shown to be a viable, pluripotent source for stem cells that can be differentiated into a variety of cell lineages, including bone, muscle and neural cell types.
Human umbilical cord blood has received increased attention in recent years as a viable source for pluripotent stem cells that can be used in a wide array of applications.
As the nation ages, an estimated 44 million Americans, including at least half of those ages 50 and older, are at risk for osteoporosis, making their bones fragile and vulnerable to serious fractures.
Researchers at the Ontario Cancer Institute at Princess Margaret Hospital have successfully proven that cancer cells alone can be killed by a new cancer drug that is triggered by a laser light, a process known as photodynamic therapy (PDT).
Governor Jim Doyle gave a $1 million boost to a University of Wisconsin-Madison spin-off company during a visit to the campus lab that gave birth to its technology.
No one is at zero risk for stroke, which explains why it is vital to know the signs and understand how to decrease the chance of experiencing a stroke.
Fatigue is one of the most common and distressing symptoms cancer patients experience during chemotherapy and radiation treatment, but it’s difficult for health care professionals to accurately assess its severity.
A U.S. Supreme Court decision in favor of KSR International Corp. on Monday strengthens challenges against overreaching human embryonic stem cell patents held by an affiliate of the University of Wisconsin, the Foundation for Taxpayer and Consumer Rights (FTCR) and the Public Patent Foundation (PUBPAT) said today.